Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,989 | -28,454 | -20,706 | -14,088 | -7,145 |
| Depreciation Amortization | 19 | 65 | 48 | 30 | 14 |
| Other Working Capital | 98 | 1,869 | 1,117 | 795 | 872 |
| Other Operating Activity | 1,662 | 7,822 | 6,299 | 5,206 | 2,586 |
| Operating Cash Flow | $-9,210 | $-18,697 | $-13,242 | $-8,056 | $-3,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -58 | -48 | -48 | -31 |
| Purchase Of Investment | -7,951 | -69,781 | -63,669 | -48,781 | N/A |
| Sale Of Investment | 10,451 | 4,984 | 2,700 | N/A | N/A |
| Investing Cash Flow | $2,498 | $-64,856 | $-61,017 | $-48,829 | $-31 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 81,569 | 81,569 | 81,312 | 70,667 |
| Financing Cash Flow | $N/A | $81,569 | $81,569 | $81,312 | $70,667 |
| Beginning Cash Position | 27,108 | 29,091 | 29,091 | 29,091 | 29,091 |
| End Cash Position | 20,395 | 27,108 | 36,402 | 53,518 | 96,054 |
| Net Cash Flow | $-6,713 | $-1,984 | $7,310 | $24,427 | $66,963 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,210 | -18,697 | -13,242 | -8,056 | -3,673 |
| Capital Expenditure | -2 | -58 | -48 | -48 | -31 |
| Free Cash Flow | -9,213 | -18,756 | -13,290 | -8,104 | -3,704 |